Prognostic value of nocturnal melatonin levels as a novel marker in patients with ST-segment elevation myocardial infarction

被引：24

作者：

Dominguez-Rodriguez, A ^{[1
]}

Abreu-Gonzalez, P

Garcia-Gonzalez, M

Reiter, RJ

机构：

[1] Hosp Univ Canarias, Dept Cardiol, Tenerife, Spain

[2] Univ La Laguna, Dept Physiol, Sch Med, Tenerife, Spain

[3] Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78285 USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2006年 / 97卷 / 08期

关键词：

D O I：

10.1016/j.amjcard.2005.11.033

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

We evaluated the possible relation between circulating levels of nocturnal melatonin, C-reactive protein, and the development of adverse cardiovascular events in patients with ST-segment elevation myocardial infarction. Patients who had developed adverse events during follow-up had significantly lower nocturnal melatonin levels than patients without events. (c) 2006 Elsevier Inc. All rights reserved.

引用

页码：1162 / 1164

页数：3

共 19 条

[1]

Effects of melatonin an vascular reactivity, catecholamine levels, and blood pressure in healthy men [J].

Arangino, S ;

Cagnacci, A ;

Angiolucci, M ;

Vacca, AMB ;

Longu, G ;

Volpe, A ;

Melis, GB .

AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (09) :1417-+

[2]

ELEVATION OF C-REACTIVE PROTEIN IN ACTIVE CORONARY-ARTERY DISEASE [J].

BERK, BC ;

WEINTRAUB, WS ;

ALEXANDER, RW .

AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (03) :168-172

[3]

Influences of melatonin administration on the circulation of women [J].

Cagnacci, A ;

Arangino, S ;

Angiolucci, M ;

Maschio, E ;

Melis, GB .

AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1998, 274 (02) :R335-R338

[4]

Decreased nocturnal melatonin levels during acute myocardial infarction [J].

Domínguez-Rodríguez, A ;

Abreu-González, P ;

García, MJ ;

Sanchez, J ;

Marrero, F ;

de Armas-Trujillo, D .

JOURNAL OF PINEAL RESEARCH, 2002, 33 (04) :248-252

[5]

Elevated levels of oxidized low-density lipoprotein and impaired nocturnal synthesis of melatonin in patients with myocardial infarction [J].

Dominguez-Rodriguez, A ;

Abreu-Gonzalez, P ;

Garcia-Gonzalez, M ;

Ferrer-Hita, J ;

Vargas, M ;

Reiter, RJ .

ATHEROSCLEROSIS, 2005, 180 (01) :101-105

[6]

The melatonin receptor subtype MT2 is present in the human cardiovascular system [J].

Ekmekcioglu, C ;

Thalhammer, T ;

Humpeler, S ;

Mehrabi, MR ;

Glogar, HD ;

Hölzenbein, T ;

Markovic, O ;

Leibetseder, VJ ;

Strauss-Blasche, G ;

Marktl, W .

JOURNAL OF PINEAL RESEARCH, 2003, 35 (01) :40-44

[7]

24h variation in the expression of the mt1 melatonin receptor subtype in coronary arteries derived from patients with coronary heart disease [J].

Ekmekcioglu, C ;

Haslmayer, P ;

Philipp, C ;

Mehrabi, MR ;

Glogar, HD ;

Grimm, M ;

Thalhammer, T ;

Marktl, W .

CHRONOBIOLOGY INTERNATIONAL, 2001, 18 (06) :973-985

[8]

Expression of the MT1 melatonin receptor subtype in human coronary arteries [J].

Ekmekcioglu, C ;

Haslmayer, P ;

Philipp, C ;

Mehrabi, MR ;

Glogar, HD ;

Grimm, M ;

Leibetseder, VJ ;

Thalhammer, T ;

Marktl, W .

JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH, 2001, 21 (01) :85-91

[9]

Melatonin inhibits oxidative modification of human low-density lipoprotein [J].

Kelly, MR ;

Loo, G .

JOURNAL OF PINEAL RESEARCH, 1997, 22 (04) :203-209

[10]

Nishiyama K, 2001, Am Heart J, V141, pE9, DOI 10.1067/mhj.2001.114368

← 1 2 →